Colorectal cancer that is caught in the early stages has a 5-year survival rate of over 90%.1 Yet, only 39% of cases2 are diagnosed in early stages due to low screening rates. When disease spreads to distant organs, the 5-year survival rate drops to 11%.3
Fortunately, Quest Diagnostics can help you and your patients screen for signs of colorectal cancer and other gastrointestinal disorders that bleed.
InSure® ONE™ aids in the detection of lower gastrointestinal bleeding that may be caused by colorectal cancer or other lower gastrointestinal disorders.* Reach more patients with InSure ONE.